ATX 1.64% 6.2¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-33

  1. 313 Posts.
    lightbulb Created with Sketch. 37
    That is the question seemingly unaddressed in the announcement. Reading between the lines 7 completed more than six months treatment and 2 more than 10 months.
    Assuming that the 2 patients are not a subset on the 7, that means it appears 5 of 14 didn’t survive 6 months. If median survival is 5.5 months this suggests the median survival isn’t much longer with use of Amplia’s agent.
    Cue the outrage from the true believers.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
0.001(1.64%)
Mkt cap ! $16.84M
Open High Low Value Volume
6.1¢ 6.4¢ 6.1¢ $2.155K 35.07K

Buyers (Bids)

No. Vol. Price($)
1 59863 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 67722 1
View Market Depth
Last trade - 15.45pm 28/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.